Industry: Service & Software
Published Date: 2026-08-01
Pages: 194 Pages
Report ld: 6769242
Request Sample
Customized Report
KEY FINDINGS
Instrument and integrated system outsourcing contributes more than one-third of modeled market revenue
Reagent control and calibrator manufacturing contributes close to three-tenths of modeled revenue
North America and Europe lead high-complexity instrument and regulated reagent programs
China and Taiwan are major manufacturing bases for rapid diagnostics consumables and point-of-care products
IVD Contract Manufacturing Service Market Size(US$)

CAGR 2026-2032
8.9%
Market Size,2032
USD 33,877
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ 18720 million in 2025 and is projected to reach US$ 33877 million, growing at a CAGR of 8.9% from 2026 to 2032.
IVD Contract Manufacturing Service refers to third-party development-transfer, industrialization and manufacturing activities performed for in vitro diagnostic product owners, diagnostic brands and medical technology companies. The market primarily covers diagnostic reagents and assay kits, calibrators and controls, lateral-flow tests, molecular diagnostic reagents, microfluidic cartridges, disposable diagnostic consumables, point-of-care readers, laboratory analyzers and related electromechanical systems. Typical service activities include reagent formulation, antibody or protein conjugation, coating and dispensing, lyophilization, filling and finishing, precision molding, microfluidic bonding, cartridge and kit assembly, electronic manufacturing, instrument integration, calibration, packaging and production validation. Engagement models range from build-to-print production and specialized process outsourcing to OEM, ODM and full-service programs integrating design transfer, supply-chain qualification, pilot production and commercial-scale manufacturing. The market focuses on outsourced activities directly associated with converting diagnostic designs and formulations into reproducible, traceable and commercially scalable IVD products under controlled medical-device quality systems.
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers
Growth is supported by the rising complexity of molecular diagnostics, point-of-care systems, home testing and multiplex assays, together with the increasing number of diagnostic developers that possess proprietary technologies but lack regulated manufacturing infrastructure. Outsourcing allows product owners to limit fixed capital expenditure, shorten industrialization schedules and access established quality, engineering and supply-chain capabilities. Regulatory requirements are also increasing the value of qualified suppliers: the US Quality Management System Regulation became effective on February 2, 2026 and incorporates ISO 13485:2016 into the medical-device quality framework, strengthening requirements for controlled processes, risk management and design transfer.
Restraints
Market expansion is constrained by long customer qualification cycles, sensitive technology-transfer requirements and the reluctance of major diagnostic companies to outsource critical formulations, algorithms or proprietary biological materials. Production volumes can be highly uneven because demand depends on regulatory approvals, clinical adoption and the commercial performance of individual diagnostic platforms. Standardized rapid-test and private-label projects face significant price pressure, while specialized biological manufacturing, validation and low-volume instrument production may carry relatively high labor, documentation and quality-control costs. Switching suppliers after regulatory approval can also require revalidation and documentation changes, limiting the addressable opportunity for new entrants.
Opportunities
The most attractive opportunities are concentrated in integrated reagent-cartridge-instrument programs, molecular assay manufacturing, microfluidic consumables, lyophilized reagents, multiplex testing and localized production for regulated markets. Emerging diagnostic companies represent an important customer group because they often require development transfer, pilot lots, registration batches and commercial production from a single partner. Additional opportunities are emerging from second-source programs, manufacturing transfers between regions, product redesign for lower cost and lifecycle support for established diagnostic platforms. Suppliers that can combine biological processing, precision consumables and instrument engineering are positioned to capture a larger share of customer program value.
Challenges
Suppliers must manage contamination risks, biological material variability, component obsolescence, stringent traceability and customer-specific change-control requirements across products with very different manufacturing profiles. Maintaining profitability is difficult when development programs fail to reach commercial scale or when customers require low-volume production with extensive validation and documentation. The industry also faces shortages of experienced quality, assay-transfer and systems-engineering personnel. Regulatory divergence across markets, cybersecurity requirements for connected instruments and dependence on single-source biological or electronic components further increase program complexity and operational risk.
INDUSTRY CHAIN ANALYSIS
The upstream supply chain includes antibodies, antigens, enzymes, nucleic-acid materials, membranes, polymers, microfluidic substrates, sensors, optical components, electronic components, packaging materials and specialized production equipment. Supplier qualification is particularly important because changes in biological reagents, membrane characteristics, plastic resins or electronic components can affect analytical performance and may trigger additional validation. The middle of the chain consists of assay-transfer specialists, reagent manufacturers, lateral-flow and microfluidic producers, precision molders, instrument OEMs and integrated contract manufacturers. Value is created through process knowledge, design for manufacturability, validation, quality documentation, yield improvement, supply-chain control and the ability to move a program from prototype or registration lots into stable commercial production.
Downstream customers include global diagnostic groups, emerging assay developers, life-science companies, pharmaceutical companies developing companion diagnostics and brands supplying laboratories, hospitals, clinics and home-testing channels. Instrument programs generally offer higher absolute project value and longer product lifecycles, while specialist reagent and consumable programs can generate recurring production revenue and stronger process-based customer retention. Profitability depends less on basic assembly labor than on project complexity, manufacturing yield, regulatory responsibility, proprietary process capability and the proportion of engineering and lifecycle services included in the customer contract.
SEGMENT INSIGHTS
By deliverable type, diagnostic instruments and integrated systems represent the largest modeled value pool, accounting for more than one-third of industry revenue because analyzers and point-of-care platforms require extensive engineering, electronics, fluidics, calibration and lifecycle support. Diagnostic reagents, controls and calibrators account for close to three-tenths of modeled revenue and form a more recurring production base. Microfluidic cartridges, molded consumables and rapid diagnostic products together represent approximately one-quarter of the market, although their competitive conditions differ substantially: precision cartridges and biosensor consumables benefit from increasing technical complexity, while standardized lateral-flow private-label manufacturing remains more price-sensitive.
DOWNSTREAM MARKET OPPORTUNITIES
Central laboratories remain the principal destination for complex analyzers, automated systems and high-throughput reagent programs, while decentralized testing is creating broader opportunities in clinics, pharmacies, emergency care and home settings. Point-of-care and home-testing products require compact instruments, stable room-temperature reagents, simple sample handling and high-volume disposable production, creating demand for suppliers that can coordinate assay, cartridge and reader development. Molecular diagnostics, companion diagnostics and multiplex testing offer additional opportunities because emerging developers frequently require external support for technology transfer, registration lots and commercial scale-up. Established diagnostic companies also generate demand through second sourcing, regional localization and redesign of mature platforms to reduce cost or address component obsolescence.
REGIONAL INSIGHTS

Fastest-Growing Region: Asia Pacific
North America is the principal high-value demand center for IVD Contract Manufacturing Service, supported by a large diagnostic innovation base, numerous specialist reagent manufacturers and a strong concentration of regulated medical-device contract manufacturers. The region is particularly important for molecular diagnostic reagents, controls, complex instruments and development-transfer services. The implementation of the FDA Quality Management System Regulation from February 2, 2026 reinforces demand for suppliers with established ISO 13485-aligned processes, risk management and inspection readiness.
BY TYPE,2021-2032(US $ MILLION)
Diagnostic Reagents and Assay Kits
Controls and Reference Materials
Lateral-flow Tests and Rapid-test Devices
Microfluidic Cartridges and Disposable Consumables
Others
BY APPLICATION,2021-2032(US $ MILLION)
Central Laboratory Testing
Point-of-Care Testing
Home and Self-testing
Others
Europe has a dense base of specialist instrument, immunodiagnostic, microfluidic and lateral-flow suppliers, with Germany, the United Kingdom, Switzerland and Northern Europe playing important roles. Four EUDAMED modules became mandatory on May 28, 2026, increasing the operational importance of device registration, certificate information and supply-chain traceability. China and Taiwan provide substantial capacity in rapid diagnostics, molded consumables, diagnostic materials and point-of-care products, while Southeast Asia is attracting selected regional manufacturing transfers. Japan retains strengths in precision instruments, immunodiagnostics and clinical chemistry. South Korea and India have meaningful IVD production capacity, but their publicly verifiable third-party contract manufacturing bases remain less developed than their branded diagnostic industries.
COMPETITIVE LANDSCAPE ANALYSIS
The market has a layered and moderately fragmented competitive structure. Large global electronics and medical manufacturing groups compete for complex instruments and multinational supply programs through manufacturing scale, procurement capability and regional production networks. Specialist IVD contract manufacturers compete through assay-transfer expertise, biological processing, lyophilization, controls, lateral-flow manufacturing, microfluidics or instrument engineering. Regional OEM and private-label suppliers serve standardized rapid diagnostics and price-sensitive customers, particularly in Asia. Competitive advantage increasingly depends on the ability to integrate reagents, consumables and instruments, support regulatory validation and retain programs throughout the product lifecycle. Strategic transactions have combined instrument development with contract manufacturing and have expanded suppliers from individual technical services into broader outsourcing platforms.
REPORT SCOPE
This report provides a comprehensive view of the global market for IVD Contract Manufacturing Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The IVD Contract Manufacturing Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding IVD Contract Manufacturing Service.
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the IVD Contract Manufacturing Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents IVD Contract Manufacturing Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents IVD Contract Manufacturing Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 IVD Contract Manufacturing Service Product Introduction
1.2 Global IVD Contract Manufacturing Service Market Size Forecast (2021–2032)
1.3 IVD Contract Manufacturing Service Market Trends & Drivers
1.3.1 IVD Contract Manufacturing Service Industry Trends
1.3.2 IVD Contract Manufacturing Service Market Drivers & Opportunities
1.3.3 IVD Contract Manufacturing Service Market Challenges
1.3.4 IVD Contract Manufacturing Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global IVD Contract Manufacturing Service Players Revenue Ranking (2025)
2.2 Global IVD Contract Manufacturing Service Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies IVD Contract Manufacturing Service Product Offerings
2.5 Key Companies General Availability (GA) Timeline for IVD Contract Manufacturing Service
2.6 IVD Contract Manufacturing Service Market Competitive Analysis
2.6.1 IVD Contract Manufacturing Service Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by IVD Contract Manufacturing Service Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on IVD Contract Manufacturing Service revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation IVD Contract Manufacturing Service Market Classification
3.1 Introduction by Type
3.1.1 Diagnostic Reagents and Assay Kits
3.1.2 Controls and Reference Materials
3.1.3 Lateral-flow Tests and Rapid-test Devices
3.1.4 Microfluidic Cartridges and Disposable Consumables
3.1.5 Others
3.1.6 Global IVD Contract Manufacturing Service Sales Value by Type
3.1.6.1 Global IVD Contract Manufacturing Service Sales Value by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global IVD Contract Manufacturing Service Sales Value, by Type (2021–2032)
3.1.6.3 Global IVD Contract Manufacturing Service Sales Value, by Type (%), 2021–2032
3.2 Introduction by Service Model
3.2.1 Build-to-Print Contract Manufacturing
3.2.2 Technology Transfer and Scale-up Manufacturing
3.2.3 Full-service CDMO
3.2.4 Others
3.2.5 Global IVD Contract Manufacturing Service Sales Value by Service Model
3.2.5.1 Global IVD Contract Manufacturing Service Sales Value by Service Model (2021 vs 2025 vs 2032)
3.2.5.2 Global IVD Contract Manufacturing Service Sales Value, by Service Model (2021–2032)
3.2.5.3 Global IVD Contract Manufacturing Service Sales Value, by Service Model (%), 2021–2032
3.3 Introduction by Diagnostic Technology Platform
3.3.1 Immunodiagnostics
3.3.2 Molecular Diagnostics
3.3.3 Clinical Chemistry
3.3.4 Others
3.3.5 Global IVD Contract Manufacturing Service Sales Value by Diagnostic Technology Platform
3.3.5.1 Global IVD Contract Manufacturing Service Sales Value by Diagnostic Technology Platform (2021 vs 2025 vs 2032)
3.3.5.2 Global IVD Contract Manufacturing Service Sales Value, by Diagnostic Technology Platform (2021–2032)
3.3.5.3 Global IVD Contract Manufacturing Service Sales Value, by Diagnostic Technology Platform (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Central Laboratory Testing
4.1.2 Point-of-Care Testing
4.1.3 Home and Self-testing
4.1.4 Others
4.2 Global IVD Contract Manufacturing Service Sales Value by Application
4.2.1 Global IVD Contract Manufacturing Service Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global IVD Contract Manufacturing Service Sales Value by Application (2021–2032)
4.2.3 Global IVD Contract Manufacturing Service Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global IVD Contract Manufacturing Service Sales Value by Region
5.1.1 Global IVD Contract Manufacturing Service Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global IVD Contract Manufacturing Service Sales Value by Region (2021–2026)
5.1.3 Global IVD Contract Manufacturing Service Sales Value by Region (2027–2032)
5.1.4 Global IVD Contract Manufacturing Service Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America IVD Contract Manufacturing Service Sales Value, 2021–2032
5.2.2 North America IVD Contract Manufacturing Service Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe IVD Contract Manufacturing Service Sales Value, 2021–2032
5.3.2 Europe IVD Contract Manufacturing Service Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific IVD Contract Manufacturing Service Sales Value, 2021–2032
5.4.2 Asia Pacific IVD Contract Manufacturing Service Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America IVD Contract Manufacturing Service Sales Value, 2021–2032
5.5.2 South America IVD Contract Manufacturing Service Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa IVD Contract Manufacturing Service Sales Value, 2021–2032
5.6.2 Middle East & Africa IVD Contract Manufacturing Service Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions IVD Contract Manufacturing Service Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions IVD Contract Manufacturing Service Sales Value, 2021–2032
6.3 United States
6.3.1 United States IVD Contract Manufacturing Service Sales Value, 2021–2032
6.3.2 United States IVD Contract Manufacturing Service Sales Value by Type (%), 2025 vs 2032
6.3.3 United States IVD Contract Manufacturing Service Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe IVD Contract Manufacturing Service Sales Value, 2021–2032
6.4.2 Europe IVD Contract Manufacturing Service Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe IVD Contract Manufacturing Service Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China IVD Contract Manufacturing Service Sales Value, 2021–2032
6.5.2 China IVD Contract Manufacturing Service Sales Value by Type (%), 2025 vs 2032
6.5.3 China IVD Contract Manufacturing Service Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan IVD Contract Manufacturing Service Sales Value, 2021–2032
6.6.2 Japan IVD Contract Manufacturing Service Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan IVD Contract Manufacturing Service Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea IVD Contract Manufacturing Service Sales Value, 2021–2032
6.7.2 South Korea IVD Contract Manufacturing Service Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea IVD Contract Manufacturing Service Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia IVD Contract Manufacturing Service Sales Value, 2021–2032
6.8.2 Southeast Asia IVD Contract Manufacturing Service Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia IVD Contract Manufacturing Service Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India IVD Contract Manufacturing Service Sales Value, 2021–2032
6.9.2 India IVD Contract Manufacturing Service Sales Value by Type (%), 2025 vs 2032
6.9.3 India IVD Contract Manufacturing Service Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Jabil Inc.
7.1.1 Jabil Inc. Profile
7.1.2 Jabil Inc. Main Business
7.1.3 Jabil Inc. IVD Contract Manufacturing Service Products, Services, and Solutions
7.1.4 Jabil Inc. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.1.5 Jabil Inc. Recent Developments
7.2 Flex Ltd.
7.2.1 Flex Ltd. Profile
7.2.2 Flex Ltd. Main Business
7.2.3 Flex Ltd. IVD Contract Manufacturing Service Products, Services, and Solutions
7.2.4 Flex Ltd. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.2.5 Flex Ltd. Recent Developments
7.3 Thermo Fisher Scientific Inc.
7.3.1 Thermo Fisher Scientific Inc. Profile
7.3.2 Thermo Fisher Scientific Inc. Main Business
7.3.3 Thermo Fisher Scientific Inc. IVD Contract Manufacturing Service Products, Services, and Solutions
7.3.4 Thermo Fisher Scientific Inc. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.3.5 Thermo Fisher Scientific Inc. Recent Developments
7.4 Sanmina Corporation
7.4.1 Sanmina Corporation Profile
7.4.2 Sanmina Corporation Main Business
7.4.3 Sanmina Corporation IVD Contract Manufacturing Service Products, Services, and Solutions
7.4.4 Sanmina Corporation IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.4.5 Sanmina Corporation Recent Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Profile
7.5.2 Merck KGaA Main Business
7.5.3 Merck KGaA IVD Contract Manufacturing Service Products, Services, and Solutions
7.5.4 Merck KGaA IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.5.5 Merck KGaA Recent Developments
7.6 Celestica Inc.
7.6.1 Celestica Inc. Profile
7.6.2 Celestica Inc. Main Business
7.6.3 Celestica Inc. IVD Contract Manufacturing Service Products, Services, and Solutions
7.6.4 Celestica Inc. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.6.5 Celestica Inc. Recent Developments
7.7 Tecan Group Ltd.
7.7.1 Tecan Group Ltd. Profile
7.7.2 Tecan Group Ltd. Main Business
7.7.3 Tecan Group Ltd. IVD Contract Manufacturing Service Products, Services, and Solutions
7.7.4 Tecan Group Ltd. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.7.5 Tecan Group Ltd. Recent Developments
7.8 Molex, LLC
7.8.1 Molex, LLC Profile
7.8.2 Molex, LLC Main Business
7.8.3 Molex, LLC IVD Contract Manufacturing Service Products, Services, and Solutions
7.8.4 Molex, LLC IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.8.5 Molex, LLC Recent Developments
7.9 TE Connectivity plc
7.9.1 TE Connectivity plc Profile
7.9.2 TE Connectivity plc Main Business
7.9.3 TE Connectivity plc IVD Contract Manufacturing Service Products, Services, and Solutions
7.9.4 TE Connectivity plc IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.9.5 TE Connectivity plc Recent Developments
7.10 STRATEC SE
7.10.1 STRATEC SE Profile
7.10.2 STRATEC SE Main Business
7.10.3 STRATEC SE IVD Contract Manufacturing Service Products, Services, and Solutions
7.10.4 STRATEC SE IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.10.5 STRATEC SE Recent Developments
7.11 Bio-Techne Corporation
7.11.1 Bio-Techne Corporation Profile
7.11.2 Bio-Techne Corporation Main Business
7.11.3 Bio-Techne Corporation IVD Contract Manufacturing Service Products, Services, and Solutions
7.11.4 Bio-Techne Corporation IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.11.5 Bio-Techne Corporation Recent Developments
7.12 H.U. Group Holdings
7.12.1 H.U. Group Holdings Profile
7.12.2 H.U. Group Holdings Main Business
7.12.3 H.U. Group Holdings IVD Contract Manufacturing Service Products, Services, and Solutions
7.12.4 H.U. Group Holdings IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.12.5 H.U. Group Holdings Recent Developments
7.13 PHC Holdings Corporation
7.13.1 PHC Holdings Corporation Profile
7.13.2 PHC Holdings Corporation Main Business
7.13.3 PHC Holdings Corporation IVD Contract Manufacturing Service Products, Services, and Solutions
7.13.4 PHC Holdings Corporation IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.13.5 PHC Holdings Corporation Recent Developments
7.14 SEKISUI CHEMICAL CO., LTD.
7.14.1 SEKISUI CHEMICAL CO., LTD. Profile
7.14.2 SEKISUI CHEMICAL CO., LTD. Main Business
7.14.3 SEKISUI CHEMICAL CO., LTD. IVD Contract Manufacturing Service Products, Services, and Solutions
7.14.4 SEKISUI CHEMICAL CO., LTD. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.14.5 SEKISUI CHEMICAL CO., LTD. Recent Developments
7.15 Plexus Corp.
7.15.1 Plexus Corp. Profile
7.15.2 Plexus Corp. Main Business
7.15.3 Plexus Corp. IVD Contract Manufacturing Service Products, Services, and Solutions
7.15.4 Plexus Corp. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.15.5 Plexus Corp. Recent Developments
7.16 SMC Ltd.
7.16.1 SMC Ltd. Profile
7.16.2 SMC Ltd. Main Business
7.16.3 SMC Ltd. IVD Contract Manufacturing Service Products, Services, and Solutions
7.16.4 SMC Ltd. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.16.5 SMC Ltd. Recent Developments
7.17 Benchmark Electronics, Inc.
7.17.1 Benchmark Electronics, Inc. Profile
7.17.2 Benchmark Electronics, Inc. Main Business
7.17.3 Benchmark Electronics, Inc. IVD Contract Manufacturing Service Products, Services, and Solutions
7.17.4 Benchmark Electronics, Inc. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.17.5 Benchmark Electronics, Inc. Recent Developments
7.18 Invetech Group
7.18.1 Invetech Group Profile
7.18.2 Invetech Group Main Business
7.18.3 Invetech Group IVD Contract Manufacturing Service Products, Services, and Solutions
7.18.4 Invetech Group IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.18.5 Invetech Group Recent Developments
7.19 Planet Innovation Holdings Limited
7.19.1 Planet Innovation Holdings Limited Profile
7.19.2 Planet Innovation Holdings Limited Main Business
7.19.3 Planet Innovation Holdings Limited IVD Contract Manufacturing Service Products, Services, and Solutions
7.19.4 Planet Innovation Holdings Limited IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.19.5 Planet Innovation Holdings Limited Recent Developments
7.20 LRE Medical GmbH
7.20.1 LRE Medical GmbH Profile
7.20.2 LRE Medical GmbH Main Business
7.20.3 LRE Medical GmbH IVD Contract Manufacturing Service Products, Services, and Solutions
7.20.4 LRE Medical GmbH IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.20.5 LRE Medical GmbH Recent Developments
7.21 Randox Laboratories Ltd.
7.21.1 Randox Laboratories Ltd. Profile
7.21.2 Randox Laboratories Ltd. Main Business
7.21.3 Randox Laboratories Ltd. IVD Contract Manufacturing Service Products, Services, and Solutions
7.21.4 Randox Laboratories Ltd. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.21.5 Randox Laboratories Ltd. Recent Developments
7.22 Fortis Life Sciences, LLC
7.22.1 Fortis Life Sciences, LLC Profile
7.22.2 Fortis Life Sciences, LLC Main Business
7.22.3 Fortis Life Sciences, LLC IVD Contract Manufacturing Service Products, Services, and Solutions
7.22.4 Fortis Life Sciences, LLC IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.22.5 Fortis Life Sciences, LLC Recent Developments
7.23 Fapon Biotech Inc.
7.23.1 Fapon Biotech Inc. Profile
7.23.2 Fapon Biotech Inc. Main Business
7.23.3 Fapon Biotech Inc. IVD Contract Manufacturing Service Products, Services, and Solutions
7.23.4 Fapon Biotech Inc. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.23.5 Fapon Biotech Inc. Recent Developments
7.24 BBI Solutions
7.24.1 BBI Solutions Profile
7.24.2 BBI Solutions Main Business
7.24.3 BBI Solutions IVD Contract Manufacturing Service Products, Services, and Solutions
7.24.4 BBI Solutions IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.24.5 BBI Solutions Recent Developments
7.25 Argonaut Manufacturing Services, Inc.
7.25.1 Argonaut Manufacturing Services, Inc. Profile
7.25.2 Argonaut Manufacturing Services, Inc. Main Business
7.25.3 Argonaut Manufacturing Services, Inc. IVD Contract Manufacturing Service Products, Services, and Solutions
7.25.4 Argonaut Manufacturing Services, Inc. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.25.5 Argonaut Manufacturing Services, Inc. Recent Developments
7.26 Life Science Outsourcing, Inc.
7.26.1 Life Science Outsourcing, Inc. Profile
7.26.2 Life Science Outsourcing, Inc. Main Business
7.26.3 Life Science Outsourcing, Inc. IVD Contract Manufacturing Service Products, Services, and Solutions
7.26.4 Life Science Outsourcing, Inc. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.26.5 Life Science Outsourcing, Inc. Recent Developments
7.27 DCN Dx
7.27.1 DCN Dx Profile
7.27.2 DCN Dx Main Business
7.27.3 DCN Dx IVD Contract Manufacturing Service Products, Services, and Solutions
7.27.4 DCN Dx IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.27.5 DCN Dx Recent Developments
7.28 Abingdon Health plc
7.28.1 Abingdon Health plc Profile
7.28.2 Abingdon Health plc Main Business
7.28.3 Abingdon Health plc IVD Contract Manufacturing Service Products, Services, and Solutions
7.28.4 Abingdon Health plc IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.28.5 Abingdon Health plc Recent Developments
7.29 SCIENION GmbH
7.29.1 SCIENION GmbH Profile
7.29.2 SCIENION GmbH Main Business
7.29.3 SCIENION GmbH IVD Contract Manufacturing Service Products, Services, and Solutions
7.29.4 SCIENION GmbH IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.29.5 SCIENION GmbH Recent Developments
7.30 Microcoat Biotechnologie GmbH
7.30.1 Microcoat Biotechnologie GmbH Profile
7.30.2 Microcoat Biotechnologie GmbH Main Business
7.30.3 Microcoat Biotechnologie GmbH IVD Contract Manufacturing Service Products, Services, and Solutions
7.30.4 Microcoat Biotechnologie GmbH IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.30.5 Microcoat Biotechnologie GmbH Recent Developments
7.31 DiaSys Diagnostic Systems GmbH
7.31.1 DiaSys Diagnostic Systems GmbH Profile
7.31.2 DiaSys Diagnostic Systems GmbH Main Business
7.31.3 DiaSys Diagnostic Systems GmbH IVD Contract Manufacturing Service Products, Services, and Solutions
7.31.4 DiaSys Diagnostic Systems GmbH IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.31.5 DiaSys Diagnostic Systems GmbH Recent Developments
7.32 EKF Diagnostics Holdings plc
7.32.1 EKF Diagnostics Holdings plc Profile
7.32.2 EKF Diagnostics Holdings plc Main Business
7.32.3 EKF Diagnostics Holdings plc IVD Contract Manufacturing Service Products, Services, and Solutions
7.32.4 EKF Diagnostics Holdings plc IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.32.5 EKF Diagnostics Holdings plc Recent Developments
7.33 Operon S.A.
7.33.1 Operon S.A. Profile
7.33.2 Operon S.A. Main Business
7.33.3 Operon S.A. IVD Contract Manufacturing Service Products, Services, and Solutions
7.33.4 Operon S.A. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.33.5 Operon S.A. Recent Developments
7.34 Future Diagnostics Solutions B.V.
7.34.1 Future Diagnostics Solutions B.V. Profile
7.34.2 Future Diagnostics Solutions B.V. Main Business
7.34.3 Future Diagnostics Solutions B.V. IVD Contract Manufacturing Service Products, Services, and Solutions
7.34.4 Future Diagnostics Solutions B.V. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.34.5 Future Diagnostics Solutions B.V. Recent Developments
7.35 Uniogen Oy
7.35.1 Uniogen Oy Profile
7.35.2 Uniogen Oy Main Business
7.35.3 Uniogen Oy IVD Contract Manufacturing Service Products, Services, and Solutions
7.35.4 Uniogen Oy IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.35.5 Uniogen Oy Recent Developments
7.36 JOYSBIO Biotechnology Co., Ltd.
7.36.1 JOYSBIO Biotechnology Co., Ltd. Profile
7.36.2 JOYSBIO Biotechnology Co., Ltd. Main Business
7.36.3 JOYSBIO Biotechnology Co., Ltd. IVD Contract Manufacturing Service Products, Services, and Solutions
7.36.4 JOYSBIO Biotechnology Co., Ltd. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.36.5 JOYSBIO Biotechnology Co., Ltd. Recent Developments
7.37 Assure Tech (Hangzhou) Co., Ltd.
7.37.1 Assure Tech (Hangzhou) Co., Ltd. Profile
7.37.2 Assure Tech (Hangzhou) Co., Ltd. Main Business
7.37.3 Assure Tech (Hangzhou) Co., Ltd. IVD Contract Manufacturing Service Products, Services, and Solutions
7.37.4 Assure Tech (Hangzhou) Co., Ltd. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.37.5 Assure Tech (Hangzhou) Co., Ltd. Recent Developments
7.38 TaiDoc Technology Corporation
7.38.1 TaiDoc Technology Corporation Profile
7.38.2 TaiDoc Technology Corporation Main Business
7.38.3 TaiDoc Technology Corporation IVD Contract Manufacturing Service Products, Services, and Solutions
7.38.4 TaiDoc Technology Corporation IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.38.5 TaiDoc Technology Corporation Recent Developments
7.39 Firstep Bioresearch, Inc.
7.39.1 Firstep Bioresearch, Inc. Profile
7.39.2 Firstep Bioresearch, Inc. Main Business
7.39.3 Firstep Bioresearch, Inc. IVD Contract Manufacturing Service Products, Services, and Solutions
7.39.4 Firstep Bioresearch, Inc. IVD Contract Manufacturing Service Revenue (US$ Million), 2021–2026
7.39.5 Firstep Bioresearch, Inc. Recent Developments
8 Industry Chain Analysis
8.1 IVD Contract Manufacturing Service Value Chain
8.2 IVD Contract Manufacturing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 IVD Contract Manufacturing Service Sales Model
8.5.2 Sales Channels
8.5.3 IVD Contract Manufacturing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global IVD Contract Manufacturing Service market size was US$ 18720 million in 2025 and is forecast to reach a readjusted size of US$ 33877 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published Date: 2026-08-01
Pages: 186
USD 4250.00
(Single User License)
The global IVD Contract Manufacturing Service market is projected to grow from US$ 18720 million in 2025 to US$ 33877 million by 2032, at a CAGR of 8.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-01
Pages: 193
USD 4900.00
(Single User License)
The global IVD Contract Manufacturing Service market was valued at US$ 18720 million in 2025 and is anticipated to reach US$ 33877 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-08-01
Pages: 181
USD 2900.00
(Single User License)
The global IVD Contract Manufacturing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 104
USD 4250.00
(Single User License)
The global IVD Contract Manufacturing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 152
USD 4900.00
(Single User License)
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 122
USD 3950.00
(Single User License)
The global market for IVD Contract Manufacturing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-07
Pages: 93
USD 2900.00
(Single User License)
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 124
USD 3950.00
(Single User License)
The global IVD Contract Manufacturing Service market size was US$ 18720 million in 2025 and is forecast to reach a readjusted size of US$ 33877 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published: 2026-08-01
Pages: 186
The global IVD Contract Manufacturing Service market is projected to grow from US$ 18720 million in 2025 to US$ 33877 million by 2032, at a CAGR of 8.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-01
Pages: 193
The global IVD Contract Manufacturing Service market was valued at US$ 18720 million in 2025 and is anticipated to reach US$ 33877 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-08-01
Pages: 181
The global IVD Contract Manufacturing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 104
The global IVD Contract Manufacturing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 152
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 122
The global market for IVD Contract Manufacturing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 93
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 124
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
INDUSTRY CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
COMPETITIVE LANDSCAPE ANALYSIS
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now